English | Español

Novartis
Ruth de Jauregui | Jun 7, 2017

Bristol-Myers Squibb, Novartis to study combination treatment for colorectal cancer
Erianne Leatherman | Jun 6, 2017

Novartis highlighting cancer care data at national, international forums
Erianne Leatherman | Jun 6, 2017

Zykadia under consideration in Europe for expanded use to treat non-small cell lung cancer
Robert Hadley | Jun 3, 2017

FDA OKs Novartis' Zykadia for metastatic lung cancer affecting the brain
Robert Hadley | May 28, 2017

Bronchodilators equal corticosteroids for COPD use, Novartis study claims 
Ruth de Jauregui | May 21, 2017

Novartis Foundation announces new initiative on World Hypertension Day
Robert Hadley | May 3, 2017

Clinical trial results offer hope for multiple sclerosis sufferers
Erianne Leatherman | Apr 30, 2017

Amgen, Novartis broaden partnership for erenumab

Trending
+ Pharmaceuticals
Patient Daily | Jun 10, 2025

Radiation oncologist on 340B program: ‘It is used as a consolidation tool by large institutions to kill competition in the market’
+ Pharmaceuticals
Patient Daily | Jun 5, 2025

Exon 20 Group questions effectiveness of 340B drug program
+ Pharmaceuticals
Patient Daily | Jun 9, 2025

Director of Public Affairs of PhRMA: ‘There is also evidence that 340B is harming state and federal budgets’
+ Pharmaceuticals
Patient Daily | Jun 5, 2025

New study identifies indicators for HER2+ breast cancer therapy response